Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/21/1995 | EP0658345A1 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
06/21/1995 | EP0658205A1 Lipoprotein associated phospholipase a 2?, inhibitors thereof and use of the same in diagnosis and therapy |
06/21/1995 | EP0658203A1 Modified fungal cells and method for producing recombinant products |
06/21/1995 | EP0658201A1 Dna sequences involved in the secondary metabolite biosynthesis by myxobacteria |
06/21/1995 | EP0658200A1 Glucagon receptors |
06/21/1995 | EP0658199A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
06/21/1995 | EP0658198A1 Multicistronic expression units and their use |
06/21/1995 | EP0658197A1 Targeted replacement of a gene without endogenous and selectable residual sequences |
06/21/1995 | EP0658194A1 Mammalian multipotent neural stem cells |
06/21/1995 | EP0658170A1 Glucagon antagonists and methods for detecting glucagon antagonists |
06/21/1995 | EP0658168A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
06/21/1995 | EP0658113A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
06/21/1995 | EP0511970B1 Method for preparing an enzymatic hydrolyzate |
06/21/1995 | EP0458959B1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
06/21/1995 | EP0431171B1 Monoclonal antibody against c-reactive protein |
06/20/1995 | US5426181 DNA encoding cytokine-induced protein, TSG-14 |
06/20/1995 | US5426051 Plasmid containing gene and expression control region for the gene, for homologous recombination with vaccinia virus |
06/20/1995 | US5426048 DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor |
06/20/1995 | US5426044 Minactivin compositions and antibodies to minactivin |
06/20/1995 | US5426037 Filling dialysis tube with hybridomas; bubble; oscillation |
06/20/1995 | US5426031 Extraction methods for preparing thromboplastin reagents |
06/18/1995 | CA2138349A1 Method for decoloring human serum albumin |
06/16/1995 | CA2138101A1 Methods for producing protein c |
06/15/1995 | WO1995016205A1 Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction |
06/15/1995 | WO1995016051A2 Methods and compositions for the suppression of neu mediated transformation |
06/15/1995 | WO1995016046A1 Regulatory nucleic acid sequences and uses thereof |
06/15/1995 | WO1995016038A2 Humanized antibodies and uses thereof |
06/15/1995 | WO1995016036A2 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF |
06/15/1995 | WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
06/15/1995 | WO1995016034A1 Mutants of bone morphogenetic proteins |
06/15/1995 | WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
06/15/1995 | WO1995016029A1 Mutants of a thermostable neutral protease from bacillus |
06/15/1995 | WO1995016027A1 Method of selecting specific bacteriophages |
06/15/1995 | WO1995016026A1 Reagents and methods for the detection of methotrexate |
06/15/1995 | WO1995015982A2 Process for generating specific antibodies |
06/15/1995 | WO1995015976A1 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor |
06/15/1995 | WO1995015769A1 Preparation and use of immunoconjugates |
06/15/1995 | WO1995015764A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
06/15/1995 | WO1995014233A3 Method of identifying hdm-2-specific antibodies |
06/15/1995 | WO1995011974A3 Human peroxisome proliferator activated receptor |
06/15/1995 | CA2178622A1 Humanized antibodies and uses thereof |
06/15/1995 | CA2178590A1 Reagents and methods for the detection of methotrexate |
06/15/1995 | CA2178205A1 Method of selecting specific bacteriophages |
06/15/1995 | CA2177835A1 Methods and compositions for the suppression of neu mediated transformation |
06/15/1995 | CA2177471A1 Ifn-.gamma.receptor .beta.-chain and derivatives thereof |
06/15/1995 | CA2177464A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
06/15/1995 | CA2177381A1 Novel protease ii |
06/15/1995 | CA2176825A1 C5a receptor antagonists having substantially no agonist activity |
06/14/1995 | EP0657538A2 Process to produce engineered antibodies in plants, engineered antibodies and use thereof in diagnostics and therapeutics |
06/14/1995 | EP0657536A1 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding |
06/14/1995 | EP0657533A1 Monoclonal antibodies with high cytotoxicity against the human CD16 antigen, and bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody |
06/14/1995 | EP0657532A1 HIV-3 retrovirus strains and their use |
06/14/1995 | EP0657471A1 Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours |
06/14/1995 | EP0657470A2 Monoclonal antibodies against in vivo glycated albumin |
06/14/1995 | EP0657469A1 L-Selectin cleavage site, methods of diagnosis and usage thereof |
06/14/1995 | EP0657468A1 Human stromae derived factor |
06/14/1995 | EP0657467A1 Antitumor antibiotics |
06/14/1995 | EP0657466A1 A process for refolding of (pro-)chymosin, comprising recycling of urea |
06/14/1995 | EP0657175A2 Vaccine comprising autologous epidermal growth factor and use thereof |
06/14/1995 | EP0656952A1 Cationic peptides and method for production |
06/14/1995 | EP0656950A1 Tat-derived transport polypeptides |
06/14/1995 | EP0656948A1 $i(BORDETELLA BRONCHISEPTICA) VACCINE |
06/14/1995 | EP0656947A1 Human interleukin-13 |
06/14/1995 | EP0656946A1 Immunoglobulins devoid of light chains |
06/14/1995 | EP0656945A1 Stress protein epitopes |
06/14/1995 | EP0656944A1 Human melanocyte stimulating hormone receptor |
06/14/1995 | EP0656941A1 Methods for producing members of specific binding pairs |
06/14/1995 | EP0656908A1 Use of specific binding molecules in potentiating igf-i activity |
06/14/1995 | EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
06/14/1995 | EP0656790A1 Compositions and methods for modulating rna |
06/14/1995 | EP0494260B1 Granulocyte-colony stimulating factor receptors |
06/13/1995 | US5424412 Construct comprising a promoter, a non-translated leader, and a 3'non-translated sequence that functions to cause addition of polyadenylated nucleotides to 3' end of RNA sequence |
06/13/1995 | US5424398 A polypeptide supporting with a solid as antibody inhibitor |
06/13/1995 | US5424395 Antimicrobial peptides active against plant pathogens |
06/13/1995 | US5424287 A pure protein-based extract prepared by alkaline extraction a bacterial suspension at a PH between 11 to 13; stimulants for production of prostaglandins, anticarcinogenic agents; immunology |
06/13/1995 | US5424199 Human growth hormone |
06/13/1995 | US5424197 H. saimiri-HTLV-X region vector |
06/13/1995 | US5424185 Human high-affinity neurotransmitter uptake system |
06/13/1995 | CA1335882C Process for preparing human factor viii:c employing expression vector containing chick _ -actin promoter |
06/09/1995 | EP0724646A4 Dna sequences related to isolated fragile x syndrome |
06/09/1995 | CA2136590A1 Recombinant genes expressing pp14 |
06/08/1995 | WO1995015396A1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a |
06/08/1995 | WO1995015393A1 Novel expression screening vector |
06/08/1995 | WO1995015391A2 Aspergillus expression system |
06/08/1995 | WO1995015388A1 Recombinant binding proteins and peptides |
06/08/1995 | WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
06/08/1995 | WO1995015382A1 Binding structures directed against the ca55.1 antigen |
06/08/1995 | WO1995015377A1 Plant arabinogalactan protein (agp) genes |
06/08/1995 | WO1995015341A1 Antibody against carcinoembryonic antigen (cea) |
06/08/1995 | WO1995015340A1 Monoclonal antibodies to antigens expressed by human dendritic cells |
06/08/1995 | WO1995015339A1 Antagonists to chaperonin 10 |
06/08/1995 | WO1995015338A1 Chaperonin 10 |
06/08/1995 | WO1995015331A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
06/08/1995 | WO1995015084A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
06/08/1995 | WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin |
06/08/1995 | CA2178007A1 Aspergillus expression system |
06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
06/08/1995 | CA2177988A1 Expression vector for preparing an anti-body-variable-region library |
06/08/1995 | CA2177957A1 Specific fusion nucleic acids and proteins present in human t(2;5) lymphoma, methods of detection and uses thereof |